Abbonarsi

Associations between rheumatoid arthritis, incident heart failure, and left ventricular ejection fraction - 06/04/23

Doi : 10.1016/j.ahj.2023.02.001 
Jonas Faxén, MD PhD a, b, c, , Lina Benson, MSc d, Ängla Mantel, MD PhD e, f, Gianluigi Savarese, MD PhD b, d, Camilla Hage, RN PhD b, d, Ulf Dahlström, MD PhD g, Johan Askling, MD PhD e, h, Lars H. Lund, MD PhD b, d, Daniel C. Andersson, MD PhD b, c
a Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden 
b Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden 
c Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden 
d Department of Medicine Solna, Cardiology Division, Karolinska Institutet, Stockholm, Sweden 
e Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden 
f Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden 
g Department of Cardiology and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden 
h Rheumatology, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden 

Reprint requests: Jonas Faxén, MD, PhD, Department of Cardiology, Karolinska University Hospital, 171 76 Stockholm, Sweden.Department of CardiologyKarolinska University HospitalStockholm171 76Sweden

Riassunto

Background

Rheumatoid arthritis (RA) is an independent risk factor for heart failure (HF). Yet, the association between RA and left ventricular ejection fraction (LVEF) in incident HF is not well studied, nor are outcomes of HF in RA by LVEF.

Methods

We identified incident HF patients between 2003 and 2018 through the Swedish Heart Failure Registry, enriched with data from national health registers. Using logistic regression, associations between a prior diagnosis of RA and LVEF among HF patients and vs age, sex, and geographical area matched general population controls without HF were assessed. Additionally, associations between HF with vs without a prior diagnosis of RA, by LVEF, and outcomes up to 5 years after HF diagnosis were investigated using Cox regression. LVEF was primarily dichotomized at 40% and secondarily categorized as <40%, 40% to 49%, and ≥50%. Covariates included demographics and cardiovascular comorbidities.

Results

Among 20,916 incident HF patients, 331 (1.6%) had RA vs 1,047/103,501 (1.0%) of HF-free controls. The odds ratio (OR) for RA was 1.4 (95% CI: 1.1-1.8) in LVEF<40% vs HF-free controls and 1.6 (95% CI: 1.3-2.0) in LVEF≥40% vs HF-free controls. Among HF patients, RA was more common in HF with LVEF ≥40% (1.9%) vs LVEF<40% (1.3%), corresponding to OR 1.4 (95% CI: 1.1-1.7). No associations between RA and cardiovascular outcomes were observed across LVEF. An association between RA and all-cause mortality was observed only for patients with LVEF<40% (hazard ratio: 1.4; 95% CI: 1.1-1.8).

Conclusions

RA was independently associated with incident HF, particularly HF with LVEF≥40%. RA did not associate with cardiovascular outcomes following HF diagnosis but was associated with increased risk of all-cause mortality in HF with LVEF<40%.

Il testo completo di questo articolo è disponibile in PDF.

Graphical Abstract

* The analyses were adjusted for age, sex, county of residence (only in case-control analyses), prior comorbidities (ischemic heart disease, hypertension, diabetes, atrial fibrillation/ flutter, and chronic kidney disease), and socioeconomic factors (education, disposable income, and family type).



Image, graphical abstract

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : CI, HF, HFmrEF, HFrEF, HFpEF, HR, IHD, OR, RA, SwedeHF


Mappa


© 2023  The Author(s). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 259

P. 42-51 - maggio 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • A U-shaped association between dietary phosphorus intake and new-onset hypertension: a nationwide cohort study in China
  • Qimeng Wu, Ziliang Ye, Chun Zhou, Mengyi Liu, Yuanyuan Zhang, Zhuxian Zhang, Panpan He, Rui Li, Huan Li, Sisi Yang, Yanjun Zhang, Jianping Jiang, Jing Nie, Chengzhang Liu, Xianhui Qin
| Articolo seguente Articolo seguente
  • Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial
  • Soohyung Park, Seung-Woon Rha, Byoung Geol Choi, Jang Hyun Cho, Sang Ho Park, Jin Bae Lee, Yong Hoon Kim, Sang Min Park, Jae Woong Choi, Ji Young Park, Eun-Seok Shin, Jae Beom Lee, Jon Suh, Jei Keon Chae, Young Jin Choi, Myung Ho Jeong, Kwang soo Cha, Seung Wook Lee, Ung Kim, Gi Chang Kim, Woong-Gil Choi, Yun-Hyeong Cho, Deok-kyu Cho, Jihun Ahn, Soon-Yong Suh, Se Yeon Choi, Jae Kyeong Byun, Jin Ah Cha, Soo Jin Hyun, Ji Bak Kim, Cheol Ung Choi, Chang Gyu Park

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.